{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T04:41:22Z","timestamp":1773031282128,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"vor","delay-in-days":4839,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1111\/j.1600-6143.2009.02734.x","type":"journal-article","created":{"date-parts":[[2009,7,23]],"date-time":"2009-07-23T12:55:58Z","timestamp":1248353758000},"page":"2085-2091","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":83,"title":["Antifungal Prophylaxis with Voriconazole or Itraconazole in Lung Transplant Recipients: Hepatotoxicity and Effectiveness"],"prefix":"10.1016","volume":"9","author":[{"given":"J.","family":"Cadena","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.J.","family":"Levine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.F.","family":"Angel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.R.","family":"Maxwell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Brady","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.F.","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.E.","family":"Michalek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.M.","family":"Levine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.I.","family":"Restrepo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/j.1600-6143.2009.02734.x_bib1","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1183\/09031936.04.00065004","article-title":"Lung transplant outcomes: A review of survival, graft function, physiology, health-related quality of life and cost-effectiveness.","volume":"24","author":"Studer","year":"2004","journal-title":"Eur Respir J"},{"key":"10.1111\/j.1600-6143.2009.02734.x_bib2","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.healun.2006.03.011","article-title":"International guidelines for the selection of lung transplant candidates: 2006 update\u2013a consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation.","volume":"25","author":"Orens","year":"2006","journal-title":"J Heart Lung Transplant"},{"key":"10.1111\/j.1600-6143.2009.02734.x_bib3","unstructured":"The Organ Procuremet and Transplantation Network. Transplant: Transplant Year (2006\u20132007) by age type. Available from: http\/\/www.optn.org\/latestData\/rptData.asp. Accessed December 7, 2008."},{"key":"10.1111\/j.1600-6143.2009.02734.x_bib4","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1034\/j.1399-3062.2001.003003128.x","article-title":"Infectious complications of lung transplantation.","volume":"3","author":"Alexander","year":"2001","journal-title":"Transpl Infect Dis"},{"issue":"Suppl 3","key":"10.1111\/j.1600-6143.2009.02734.x_bib5","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1034\/j.1399-3062.4.s3.4.x","article-title":"Fungal infection in lung transplantation.","volume":"4","author":"Kubak","year":"2002","journal-title":"Transpl Infect Dis"},{"key":"10.1111\/j.1600-6143.2009.02734.x_bib6","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S1053-2498(02)00477-1","article-title":"Aspergillus infections after lung transplantation: Clinical differences in type of transplant and implications for management.","volume":"22","author":"Singh","year":"2003","journal-title":"J Heart Lung Transplant"},{"key":"10.1111\/j.1600-6143.2009.02734.x_bib7","first-page":"CD004291","article-title":"Antifungal agents for preventing fungal infections in solid organ transplant recipients.","volume":"3","author":"Playford","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/j.1600-6143.2009.02734.x_bib8","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/j.healun.2003.09.028","article-title":"A survey of anti-fungal management in lung transplantation.","volume":"23","author":"Dummer","year":"2004","journal-title":"J Heart Lung Transplant"},{"key":"10.1111\/j.1600-6143.2009.02734.x_bib9","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1399-3062.2006.00156.x","article-title":"Variation in antifungal prophylaxis strategies in lung transplantation.","volume":"8","author":"Husain","year":"2006","journal-title":"Transpl Infect Dis"},{"key":"10.1111\/j.1600-6143.2009.02734.x_bib10","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1378\/chest.125.4.1224","article-title":"Transplant\/Immunology Network of the American College of Chest Physicians. A survey of clinical practice of lung transplantation in North America.","volume":"125","author":"Levine","year":"2004","journal-title":"Chest"},{"key":"10.1111\/j.1600-6143.2009.02734.x_bib11","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1016\/j.healun.2005.05.003","article-title":"Itraconazole prophylaxis in lung transplant recipients receiving tacrolimus (FK 506): Efficacy and drug interaction.","volume":"24","author":"Shitrit","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"10.1111\/j.1600-6143.2009.02734.x_bib12","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1034\/j.1399-3062.2002.t01-2-02002.x","article-title":"The incidence of invasive aspergillosis among solid organ transplant recipients and implications for prophylaxis in lung transplants.","volume":"4","author":"Minari","year":"2002","journal-title":"Transpl Infect Dis"},{"key":"10.1111\/j.1600-6143.2009.02734.x_bib13","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1034\/j.1399-3062.1999.010402.x","article-title":"Epidemiology of fungal infections in solid organ transplant patients.","volume":"1","author":"Patterson","year":"1999","journal-title":"Transpl Infect Dis"},{"key":"10.1111\/j.1600-6143.2009.02734.x_bib14","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1378\/chest.115.5.1301","article-title":"Antifungal prophylaxis during the early postoperative period of lung transplantation. Valencia Lung Transplant Group.","volume":"115","author":"Calvo","year":"1999","journal-title":"Chest"},{"key":"10.1111\/j.1600-6143.2009.02734.x_bib15","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1016\/j.transproceed.2008.09.020","article-title":"Efficiency and safety of inhaled amphotericin B lipid complex (abelcet) in the prophylaxis of invasive fungal infections following lung transplantation.","volume":"40","author":"Borro","year":"2008","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1600-6143.2009.02734.x_bib16","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1469-0691.2005.01128.x","article-title":"Aspergillus infections in lung transplant recipients: Risk factors and outcome.","volume":"11","author":"Sol\u00e9","year":"2005","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/j.1600-6143.2009.02734.x_bib17","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1111\/j.1600-6143.2006.01548.x","article-title":"Voriconazole prophylaxis in lung transplant recipients.","volume":"6","author":"Husain","year":"2006","journal-title":"Am J Transplant"},{"issue":"Suppl 10","key":"10.1111\/j.1600-6143.2009.02734.x_bib18","first-page":"110","article-title":"Fungal infections.","volume":"4","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2009.02734.x_bib19","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1378\/chest.119.1.169","article-title":"Spectrum of Aspergillus infection in lung transplant recipients: Case series and review of the literature.","volume":"119","author":"Mehrad","year":"2001","journal-title":"Chest"},{"key":"10.1111\/j.1600-6143.2009.02734.x_bib20","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1080\/00365540410019408","article-title":"Two case reports: Fatal Absidia corymbifera pulmonary tract infection in the first postoperative phase of a lung transplant patient receiving voriconazole prophylaxis, and transient bronchial Absidia corymbifera colonization in a lung transplant patient.","volume":"36","author":"Mattner","year":"2004","journal-title":"Scand J Infect Dis"},{"key":"10.1111\/j.1600-6143.2009.02734.x_bib21","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1034\/j.1399-3003.1999.13a33.x","article-title":"Pre-emptive therapy with azoles in lung transplant patients. Geneva Lung Transplantation Group.","volume":"13","author":"Hamacher","year":"1999","journal-title":"Eur Respir J"},{"key":"10.1111\/j.1600-6143.2009.02734.x_bib22","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1056\/NEJMoa020191","article-title":"Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis.","volume":"347","author":"Herbrecht","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-6143.2009.02734.x_bib23","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1086\/525258","article-title":"Treatment of aspergillosis: Clinical practice guidelines of the Infectious Diseases Society of America.","volume":"46","author":"Walsh","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"Suppl 1","key":"10.1111\/j.1600-6143.2009.02734.x_bib24","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1439-0507.2005.01112.x","article-title":"Surveillance of invasive mold infections in lung transplant recipients: Effect of antimycotic prophylaxis with Itraconzole and voriconazole.","volume":"48","author":"Mattner","year":"2005","journal-title":"Mycoses"},{"key":"10.1111\/j.1600-6143.2009.02734.x_bib25","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1001\/jama.1993.03510240069035","article-title":"A new simplified acute physiology score (SAPS II) Based on a European\/North American Multicenter Study.","volume":"270","author":"Le Gall","year":"1993","journal-title":"JAMA"},{"key":"10.1111\/j.1600-6143.2009.02734.x_bib26","unstructured":"VFEND IV VFEND Tablets VFEND for Oral Suspension. Available from: http:\/\/www.fda.gov\/cder\/foi\/label\/2006\/021266s18,021267s19,021630s10lbl.pdf. Accessed November 2008."},{"key":"10.1111\/j.1600-6143.2009.02734.x_bib27","unstructured":"DRUGDEX\u00ae System [Internet database]. Available from: http:\/\/www.micromedex.com\/about_us\/legal\/cite\/#ama. Accessed September 10, 2006."},{"key":"10.1111\/j.1600-6143.2009.02734.x_bib28","first-page":"193","article-title":"Hepatic disorders. In:Lee A, ed. Adverse Drug Reactions 2nd Ed","author":"Forrest","year":"2006","journal-title":"Pharmaceutical Press"},{"key":"10.1111\/j.1600-6143.2009.02734.x_bib29","first-page":"515","article-title":"Hepatic and cholestatic diseases. In: Tisdale JE, Miller DA, eds. Drug-Induced Diseases: Prevention, Detection, and Management","author":"MacLaren","year":"2005","journal-title":"Bethesda, MD: American Society of Health System Pharmacists,"},{"issue":"Issue","key":"10.1111\/j.1600-6143.2009.02734.x_bib30","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1086\/323335","article-title":"Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: An international consensus.","volume":"34","author":"Ascioglu","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"Issue","key":"10.1111\/j.1600-6143.2009.02734.x_bib31","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/00063198-200305000-00007","article-title":"Fungal pneumonias in transplant recipients.","volume":"9","author":"Bag","year":"2003","journal-title":"Curr Opin Pulm Med"},{"issue":"Issue","key":"10.1111\/j.1600-6143.2009.02734.x_bib32","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1080\/13693780701200372","article-title":"Fungal infections in solid organ transplantation.","volume":"45","author":"Silveira","year":"2007","journal-title":"Med Mycol"},{"issue":"Issue","key":"10.1111\/j.1600-6143.2009.02734.x_bib33","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1128\/AAC.50.5.1878-1880.2006","article-title":"Intrapulmonary penetration of voriconazole in patients receiving an oral prophylactic regimen.","volume":"50","author":"Capitano","year":"2006","journal-title":"Antimicrobial Agents Chemother"},{"issue":"Issue","key":"10.1111\/j.1600-6143.2009.02734.x_bib34","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.2165\/00003495-200262180-00010","article-title":"Voriconazole: In the treatment of invasive aspergillosis.","volume":"62","author":"Muijsers","year":"2002","journal-title":"Drugs"},{"issue":"Suppl 1","key":"10.1111\/j.1600-6143.2009.02734.x_bib35","doi-asserted-by":"crossref","first-page":"i17","DOI":"10.1093\/jac\/dki220","article-title":"Making sense of itraconzole pharmacokinetics.","volume":"56","author":"Prentice","year":"2005","journal-title":"J Antimicrob Chemother"},{"issue":"Issue","key":"10.1111\/j.1600-6143.2009.02734.x_bib36","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1034\/j.1399-3062.2000.020105.x","article-title":"Investigation and control of aspergillosis and other filamentous fungal infections in solid organ transplant recipients.","volume":"2","author":"Patterson","year":"2000","journal-title":"Transpl Infect Dis"},{"key":"10.1111\/j.1600-6143.2009.02734.x_bib37","unstructured":"Sporanox\u00ae (Itraconazole) Capsules. Available from: http:\/\/www.fda.gov\/medwatch\/SAFETY\/2001\/sporanox_label.pdf. Accessed September 1, 2006."},{"issue":"Issue","key":"10.1111\/j.1600-6143.2009.02734.x_bib38","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1128\/AAC.50.4.1570-1572.2006","article-title":"Voriconazole therapeutic drug monitoring.","volume":"50","author":"Smith","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"issue":"Issue","key":"10.1111\/j.1600-6143.2009.02734.x_bib39","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/sj.bmt.1705614","article-title":"Breakthrough zygomycosis after voriconazole administration among patients with hematologic malignancies who receive hematopoietic stem-cell transplants or intensive chemotherapy.","volume":"39","author":"Trifilio","year":"2007","journal-title":"Bone Marrow Transplant"},{"issue":"Issue","key":"10.1111\/j.1600-6143.2009.02734.x_bib40","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1086\/428780","article-title":"Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: A case-control observational study of 27 recent cases.","volume":"191","author":"Kontoyiannis","year":"2005","journal-title":"J Infect Dis"}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-6143.2009.02734.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S160061352201810X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S160061352201810X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1600-6143.2009.02734.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T04:48:39Z","timestamp":1761626919000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S160061352201810X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":40,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["S160061352201810X"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-6143.2009.02734.x","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2009,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antifungal Prophylaxis with Voriconazole or Itraconazole in Lung Transplant Recipients: Hepatotoxicity and Effectiveness","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1600-6143.2009.02734.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}